The sold production of composite diagnostic or laboratory reagents in Denmark has shown significant growth over the past decade, reaching 453.62 million Euros in 2023. The year-on-year variation in 2023 was 8.7%, reflecting consistent growth despite the fluctuations in earlier years. The data presents a stark increase of 157.65% in 2020 due to external factors possibly related to the COVID-19 pandemic. The last five years showcased a compound annual growth rate (CAGR) of 17.71%, indicating a strong upward trend.
From 2024 onwards, the production is forecasted to grow at a more moderate pace, with a five-year growth rate of 28.64%. This is consistent with a forecasted five-year CAGR of 5.17%, suggesting steady development in the market.
Future trends to watch for include advancements in biotechnology, the integration of artificial intelligence in diagnostic tools, and increasing demand for personalized medicine, which could further influence production volumes and values in Denmark’s reagent market.
- 2013: Growth of 3.01%
- 2014: Growth of 16.52%
- 2015: Growth of 12.32%
- 2016: Growth of 39.31%
- 2017: Growth of 19.45%
- 2018: Decline of 33.54%
- 2019: Decline of 2.56%
- 2020: Growth of 157.65%
- 2021: Decline of 16.7%
- 2022: Decline of 0.61%
- 2023: Growth of 8.7%
- 2028: Forecasted 5-Year CAGR of 5.17%
